Of the 71 patients with CFTR PVs, two patients had PV in other genes with either an established or possible association with increased cancer risk consisting of the L2357 frameshift variant in BRCA2 (rs80359636) and the Y179C missense variant in MUTYH (rs34612342). This evidence concerns the gene BRCA2 and cancer.